A service company dedicated to providing the highest quality human and animal islets to support the diabetes research community.

LEARN MORE

SERVICES

Working in conjunction with the Scharp-Lacy Research Institute, Prodo Labs is committed to performing research and various services to support the diabetes research community. Some of these services include human and animal islet isolations, performing assays and project-based consulting.

LEARN MORE

RESEARCH

Prodo Laboratories is committed to several research projects, including improving islet isolation efficiency and productivity, islet culturing and expanding collaboration activities encompassing both the corporate and academic diabetes communities.

LEARN MORE

Today, Not Tomorrow

Prodo Laboratories is in the service business of providing human islets for research. We pride ourselves on providing the highest quality islets, including those from both normal and Type 2 pancreases. We also provide contract-based isolations of animal pancreases, which currently include mice, rats and pigs. To ensure the highest quality islets, we utilizes our own proprietary, cGMP media which has been tested and proven to increase the recovery, functionality and viability of the cells. Please take a moment to view our product offerings and our testing services.

About Us

Prodo Laboratories, Inc was founded in Sept 2006 by David Scharp, MD to develop a biotechnology company that provides diabetes research services and products to both the academic and corporate diabetes research communities, as well as pursue its own research lines.

Our Products

Prodo Labs provides high quality human islets for research as its primary service business by direct contracts with biotechnology and pharmaceutical companies utilizing them for in vitro and in vivo testing in the development of new drugs for diabetes or in the development of new insulin-producing cells for future transplants.

Latest News

Latest News: January, 2016 – Prodo Laboratories has moved into a new research building, expanding its operations and capabilities in the diabetes research community.

Contact Us

We would love to hear from you! Fill out the form below and we will be in touch with you shortly.